2m 2m 2m 2m 2m 2m 2m
Collegium Pharma (COLL)
NASDAQ
$22.05+$0.21 (+0.94%)
Price as of Oct 02, 2026 4:10 PM EDT- $711.0MMarket Cap
- -36.29%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Collegium Pharma (COLL)
$22.05+$0.21 (+0.94%)
COLL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.84 | ||
Change | +$0.02 (+0.09%) | ||
Open | $21.94 | ||
High | $22.28 | ||
Low | $21.43 | ||
Previous Close | $21.82 | ||
Volume | 1,000,105 | ||
30-Day Average Volume | 940,243 | ||
1-Week Change | -3.53% | ||
1-Month Change | -9.00% | ||
1-Year Change | -36.29% | ||
3-Year Change | -2.28% | ||
5-Year Change | 9.42% | ||
Fundamentals | |||
Shares Outstanding | 32.6M | ||
Total Assets | $2.1B | ||
Market Cap | $711.0M | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $199.9M | ||
Net Income | -$15.1M | ||
Free Cash Flow | $70.8M | ||
EBIT | -$517,000.00 | ||
EBITDA | $62.4M | ||
Net Working Capital | $18.2M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | 27 | ||
Enterprise Value/Revenue | 8 | ||
P/B | 2 | ||
P/E | -47 | ||
PEG | 0 | ||
Price/Free Cash Flow | 10 | ||
Price/Operating Cash Flow | 10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue